Spray-dried extract of Phyllanthus niruri L. reduces mucosal damage in rats with intestinal inflammation

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 8, 2015, Pages 1107-1118

  De Melo, Maryanne Nunes ^a   Lira Soares, Luiz Alberto ^a   Da Costa Porto, Cynthia Raquel ^a   De Araújo, Aurigena Antunes ^a   Das Graças Almeida, Maria ^a   De Souza, Tatiane Pereira ^a   Petrovick, Pedro Ros ^b   De Araújo Júnior, Raimundo Fernandes ^c   Guerra, Gerlane Coelho Bernardo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

anti inflammatory; antioxidant; colitis; Phyllanthus niruri; rats

Indexed keywords

ACETIC ACID; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; PHYLLANTHUS NIRURI EXTRACT; PROTEIN P53; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; IFNG PROTEIN, HUMAN; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; NONHUMAN; OXIDATIVE STRESS; PHYLLANTHUS NIRURI; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; RAT; ULCERATIVE COLITIS; ULTRAVIOLET SPECTROPHOTOMETRY; ULTRAVIOLET VISIBLE SPECTROPHOTOMETRY; ANIMAL; COLITIS, ULCERATIVE; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; INTESTINE; METABOLISM; PATHOLOGY; PHYLLANTHUS; TUMOR SUPPRESSOR GENE; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENES, P53; GLUTATHIONE; INFLAMMATION; INTERFERON-GAMMA; INTESTINES; MALONDIALDEHYDE; PHYLLANTHUS; PLANT EXTRACTS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936993373     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12408     Document Type: Article

References (50)

1. Hendrickson BA, et al. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15: 79-94. [Epub 2002/01/10].
2. Yun J, et al. Epidemiology and gene markers of ulcerative colitis in the Chinese. World journal of gastroenterology: WJG. 2009; 15: 788-803. [Epub 2009/02/21].
3. Podolsky DK,. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429. [Epub 2002/08/09].
4. Turner JR,. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006; 169: 1901-1909. [Epub 2006/12/07].
5. Sun L, et al. Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. Curr Opin Gastroenterol 2011; 27: 321-327. [Epub 2011/04/13].
6. O'Toole A, Korzenik J,. Environmental triggers for IBD. Curr Gastroenterol Rep 2014; 16: 396, 1-6. [Epub 2014/07/23].
7. Missaghi B, et al. Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens 2014; 3: 510-527. [Epub 2014/12/02].
8. Fiocchi C,. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205. [Epub 1998/07/03].
9. Rogler G, Andus T,. Cytokines in inflammatory bowel disease. World J Surg 1998; 22: 382-389. [Epub 1998/04/02].
10. Abraham C, Cho JH,. Mechanisms of disease inflammatory bowel disease. New Engl J Med. 2009; 361: 2066-2078.
11. Zhou YH, et al. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappa Bp65, IL-6) in TNBS-induced colitis in rats. Mediat Inflamm 2006 (5), 92642: 1-9.
12. Iwamoto M, et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996; 180: 152-159. [Epub 1996/10/01].
13. Sipos F, et al. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum 2005; 48: 775-786. [Epub 2005/03/05].
14. Dirisina R, et al. p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis. Gastroenterology 2011; 141: 1036-1045. [Epub 2011/06/28].
15. Leon AJ, et al. Cytokines in the pathogenesis of inflammatory bowel diseases. Med Clin (Barc) 2006; 127: 145-152.
16. Reuter S, et al. Oxidative stress, inflammation, and cancer How are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
17. Roessner A, et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract 2008; 204: 511-524.
18. Buffinton GD, Doe WF,. Depleted mucosal antioxidant defenses in inflammatory bowel-disease. Free Radic Biol Med 1995; 19: 911-918.
19. Karp SM, Koch TR,. Oxidative stress and antioxidants in inflammatory bowel disease. Dis Mon 2006; 52: 199-207.
20. Sies H,. Oxidative Stress-from basic research to clinical-application. Am J Med 1991; 91: S31-S38.
21. Araujo RF Jr, et al. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines. World J Gastroenterol 2012; 18: 4162-6168. [Epub 2012/08/25].
22. de Araujo Junior RF, et al. A dry extract of Phyllanthus niruri protects normal cells and induces apoptosis in human liver carcinoma cells. Exp Biol Med (Maywood) 2012; 237: 1281-1288. [Epub 2012/12/15].
23. Okoli CON, et al. Extracts of Phyllanthus niruri aerial parts suppress acute and chronic inflammation in murine models. J Herbs Spices Med Plants 2014; 20: 13, 256-268.
24. Soares LALB, et al. Total flavonoid determination for the quality control of aqueous extractives from Phyllanthus niruri L. Acta Farm Bonaerense 2003; 22: 203-207.
25. De Souza TP, et al. Compression behavior of formulations from Phyllanthus niruri spray dried extract. Pharmazie 2006; 61: 213-217. [Epub 2006/04/08].
26. MacPherson BR, Pfeiffer CJ,. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135-150. [Epub 1978/01/01].
27. Millar AD, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996; 39: 407-415. [Epub 1996/09/01].
28. Bell CJ, et al. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 1995; 268 (4 Pt 1): G622-G630. [Epub 1995/04/01].
29. Krawisz JE, et al. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350. [Epub 1984/12/01].
30. Anderson ME,. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985; 113: 548-555. [Epub 1985/01/01].
31. Esterbauer H, Cheeseman KH,. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421. [Epub 1990/01/01].
32. Barreiros ALBS, et al. Estresse oxidativo: relação entre geração de espécies reativas e defesa do organismo. Química Nova. 2006; 29: 113-123.
33. Bermer OA, et al. Manual de Técnicas para Histologia Normal e Patolõgica. São Paulo: EDART, Universidade de São Paulo, 1976, 241 p.
34. Elson CO, et al. Experimental-models of inflammatory bowel-disease. Gastroenterology 1995; 109: 1344-1367.
35. Bertevello PL, et al. Immunohistochemical assessment of mucosal cytokine profile in acetic acid experimental colitis. Clinics 2005; 60: 277-286. [Epub 2005/09/03].
36. Pavlick KP, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002; 33: 311-322.
37. Circu ML, Aw TY,. Intestinal redox biology and oxidative stress. Semin Cell Dev Biol 2012; 23: 729-737.
38. Babbs CF,. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992; 13: 169-181. [Epub 1992/01/01].
39. Hagar HH, et al. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol 2007; 554: 69-77.
40. Ercin CN, et al. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci 2009; 54: 75-79.
41. Oz HS, et al. Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 2005; 16: 297-304.
42. Loguercio C, et al. Glutathione supplementation improves oxidative damage in experimental colitis. Dig Liver Dis 2003; 35: 635-641.
43. Boehm U, et al. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-795.
44. Simon AR, et al. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998; 275: C1640-C1652.
45. Comalada M, et al. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship. Biochem Pharmacol 2006; 72: 1010-1021.
46. Hur SJ, et al. Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res 2012; 32: 801-816.
47. Kotakadi VS, et al. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 2008; 29: 1799-1806.
48. Jin Y, et al. American ginseng suppresses colitis through P53-mediated apoptosis of inflammatory cells. Cancer Prev Res (Phila) 2010; 3: 339-347.
49. Durackova Z,. Some Current Insights into Oxidative Stress. Physiol Res 2010; 59: 459-469.
50. Han D, et al. Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 2009; 11: 2245-2263.